Company ProfilePremium

CV Sciences, Inc

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
CV Sciences, Inc - Healthcare showcase

Year Founded & Workforce

2010

100 Employees

Industry

Healthcare

Services

Cannabidiol Market
C

CV Sciences, Inc Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

CV Sciences, Inc Overview

Company Headquarters: Nevada, US

Founded: 2010

Workforce: ~100

Company Working: CV Sciences, Inc. is a manufacturer of safe, high-quality, and effective CBD oil products. The company is focusing on promoting healthy living through its pharmaceutical drug development efforts and portfolio of finished product brands. It is the maker of PlusCBD Oil, the leading brand in hemp-derived CBD oil products available online, in health food stores, and in practitioners' offices in the US. The company operates two business segments, including a consumer product division and a drug development division. Its drug development division involves developing and commercializing CBD-based novel therapeutics utilizing CBD, and its consumer product division involves manufacturing, marketing, and selling plant-based CBD products.

Strategy

CV Sciences, Inc. focuses on increasing its footprint globally by establishing manufacturing, R&D, and commercial operations in various regions across the world. To increase sales and marketing, the company focuses on targeted activities that include direct-to-consumer advertising to increase consumer awareness about products. It also focuses on engaging physicians and surgeons through its sales team and other programs to ensure they are fully informed about its products.

Company Snapshot

$53.7M

Revenue

100

Employees

2010

Founded

Nevada, US

Headquarters

SWOT Analysis

Strengths

  • Strong brand reputation
  • Diversified business
  • Strong distribution network

Weaknesses

  • High net losses
  • Legal issues

Opportunities

  • Increasing co-promotion agreements with strategic partners
  • Customer engagement through online channels

Threats

  • Stringent regulatory policies
  • Changing political landscape across regions

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • CV Sciences, Inc
    • Cannabidiol Market

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales fell from USD 53.7 Mn in 2019 to USD 20 Mn in 2021.
CV Sciences, Inc — By Business Segment
Series (USD Mn)201920202021
Sales53.724.420
R&D Expenditure5.92.91.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.